STUB1 and myelodysplastic syndrome: However, the current knowledge regarding the biology of hematological malignancies supports the integration of genetic predisposition and CHIP into future MDS-pCT classifications to reflect the biological diversity and etiologies of MDS-pCT and their impact on outcomes.